Yifan Zhou Selected Research

MicroRNAs (MicroRNA)

1/2022	Cerebral edema after ischemic stroke: Pathophysiology and underlying mechanisms.
12/2020	Comprehensive analysis of the relationship between competitive endogenous RNA (ceRNA) networks and tumor infiltrating-cells in hepatocellular carcinoma.
1/2020	Improving Model Performance on the Stratification of Breast Cancer Patients by Integrating Multiscale Genomic Features.
1/2020	MicroRNA-421 Inhibits Apoptosis by Downregulating Caspase-3 in Human Colorectal Cancer.
1/2018	Dysregulated MicroRNA Involvement in Multiple Sclerosis by Induction of T Helper 17 Cell Differentiation.
1/2018	OIP5 Promotes Growth, Metastasis and Chemoresistance to Cisplatin in Bladder Cancer Cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yifan Zhou Research Topics

Disease

26	Neoplasms (Cancer) 04/2024 - 01/2019
14	Inflammation (Inflammations) 05/2024 - 06/2019
9	Dry Eye Syndromes (Dry Eye Syndrome) 01/2024 - 01/2021
8	Infections 12/2024 - 01/2018
7	Ischemic Stroke 12/2023 - 01/2020
6	Stroke (Strokes) 12/2023 - 08/2015
6	COVID-19 12/2023 - 01/2022
6	Multiple Sclerosis 01/2021 - 01/2016
5	Psoriasis (Pustulosis Palmaris et Plantaris) 01/2023 - 01/2021
4	Neuralgia (Stump Neuralgia) 01/2024 - 01/2022
4	Melanoma (Melanoma, Malignant) 01/2022 - 01/2020
4	Neuromyelitis Optica (Devic's Disease) 10/2019 - 01/2016
3	Neoplasm Metastasis (Metastasis) 04/2024 - 01/2018
3	Adenocarcinoma 04/2024 - 01/2021
3	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 12/2020
3	Pain (Aches) 01/2024 - 01/2018
3	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2022
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2023 - 01/2021
3	Retinal Detachment (Retinal Detachments) 11/2022 - 06/2020
3	Fibrosis (Cirrhosis) 01/2022 - 01/2020
2	Brain Edema (Cerebral Edema) 05/2024 - 01/2022
2	Hyperemia 04/2024 - 11/2023
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 03/2024 - 02/2023
2	Cognitive Dysfunction 02/2024 - 11/2023
2	Bites and Stings (Sting) 01/2024 - 01/2021
2	Venous Thrombosis (Deep-Vein Thrombosis) 12/2023 - 01/2023
2	Hypersensitivity (Allergy) 11/2023 - 01/2022
2	Autoimmune Diseases (Autoimmune Disease) 10/2023 - 01/2017
2	Keratitis 03/2023 - 11/2020
2	Dysbiosis 01/2023 - 10/2019
2	Nervous System Diseases (Neurological Disorders) 01/2023 - 12/2022
2	Breast Neoplasms (Breast Cancer) 10/2022 - 01/2020
2	Carcinogenesis 01/2022 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2022 - 12/2018
2	Osteosarcoma (Osteogenic Sarcoma) 09/2021 - 01/2020
2	Intervertebral Disc Degeneration 01/2021 - 01/2021
2	Ganglion Cysts (Ganglion) 01/2020 - 01/2020
2	Hyperplasia 01/2017 - 10/2014
2	Neointima 03/2015 - 10/2014
2	Ischemia 02/2013 - 11/2012

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 05/2024 - 11/2012
11	CytokinesIBA 04/2024 - 01/2016
7	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2018
7	Messenger RNA (mRNA)IBA 03/2024 - 08/2015
6	VaccinesIBA 12/2023 - 01/2020
6	Retinaldehyde (Retinal)IBA 11/2022 - 01/2020
6	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2018
5	InterferonsIBA 04/2024 - 01/2020
5	Immune Checkpoint InhibitorsIBA 01/2023 - 01/2019
4	Interleukin-17 (Interleukin 17)IBA 03/2024 - 01/2021
4	RNA (Ribonucleic Acid)IBA 03/2024 - 12/2020
4	Immunoglobulin G (IgG)IBA 10/2019 - 01/2017
3	EnzymesIBA 04/2024 - 01/2021
3	ChemokinesIBA 03/2024 - 01/2016
3	Hyaluronic Acid (Hyaluronan)IBA 01/2024 - 11/2022
3	Glucose (Dextrose)FDA LinkGeneric 01/2024 - 01/2021
3	AntigensIBA 01/2021 - 01/2019
3	AntibodiesIBA 07/2020 - 01/2017
3	Neoplasm Antigens (Tumor Antigens)IBA 01/2020 - 01/2019
3	Myelin-Oligodendrocyte GlycoproteinIBA 10/2019 - 04/2017
2	Eosine Yellowish-(YS) (Eosin)IBA 05/2024 - 01/2021
2	Hematoxylin (Haematoxylon)IBA 05/2024 - 01/2021
2	Interleukin-6 (Interleukin 6)IBA 03/2024 - 01/2023
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2024 - 01/2021
2	NeuropeptidesIBA 01/2024 - 05/2023
2	Blood Glucose (Blood Sugar)IBA 01/2024 - 07/2023
2	Circulating Tumor DNAIBA 12/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 11/2023 - 01/2021
2	Oxygen (Dioxygen)IBA 11/2023 - 09/2021
2	polydopamineIBA 11/2023 - 09/2021
2	GW 4869IBA 05/2023 - 12/2022
2	Insulin (Novolin)FDA Link 03/2023 - 07/2022
2	Viral AntigensIBA 01/2023 - 01/2023
2	Imiquimod (Aldara)FDA LinkGeneric 01/2023 - 01/2021
2	Gentamicins (Gentamicin)FDA LinkGeneric 01/2023 - 01/2022
2	BerberineIBA 01/2023 - 08/2022
2	Interleukin-23 (Interleukin 23)IBA 01/2023 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2023 - 08/2015
2	HydrogelsIBA 11/2022 - 01/2019
2	Poly I-CIBA 10/2022 - 01/2020
2	Transcription Factors (Transcription Factor)IBA 01/2022 - 01/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2019
2	Phosphotransferases (Kinase)IBA 01/2022 - 11/2020
2	Caspase 1 (ICE Protease)IBA 01/2021 - 01/2021
2	Oncostatin MIBA 01/2021 - 01/2021
2	loricrinIBA 01/2021 - 01/2021
2	Neutralizing AntibodiesIBA 01/2021 - 01/2021
2	ImmunosorbentsIBA 01/2021 - 01/2021
2	Interleukin-22 (IL-22)IBA 01/2021 - 01/2021
2	Silicone OilsIBA 01/2021 - 06/2020
2	KinesinsIBA 01/2019 - 01/2019

Therapy/Procedure

18	Therapeutics 04/2024 - 10/2015
5	Immunotherapy 02/2024 - 01/2020
3	Transplantation 12/2024 - 01/2023
3	Drug Therapy (Chemotherapy) 11/2023 - 08/2022
2	Laser In Situ Keratomileusis (LASIK) 01/2024 - 08/2023
2	Lasers (Laser) 01/2024 - 08/2023
2	Euthanasia (Mercy Killing) 01/2023 - 01/2023
2	Photothermal Therapy 08/2022 - 09/2021
2	Contact Lenses 01/2022 - 01/2022